›  Technology  »   Maxells™  |  Singles™  |  Differentiation  |  ES Cell lines  |  HFF Lines



Singles™ is a breakthrough development enabling efficient culturing of human stem cells as single cells in suspension. The cells grown using the Singles™ technology are uniform, undifferentiated, self-renewable, and form single or duplicate cells in suspension. Accellta developed proprietary protocols for the differentiation of the Single cells directly in suspension to a variety of cell types (e. g., MSCs, HSCs)

  • Cell concentration: >40 million cells/ml
  • Expansion factor: Up to 60 fold increase in 7 days
  • Suitable for human pluripotent stem cells and progenitor cells
  • Better control of induced differentiation in suspension
  • Platform for genetic modification
  • High cloning efficiency
  • High recovery rates from freeze-thaw cycles
  • Does not require enzymatic splitting
  • Rock inhibitor-free, xeno-free defined medium
  • Methods for directed differentiation in suspension
  • Karyotype stability
  • High viability rate

Atlas of Human Pluripotent Stem Cells

978 1 61779 548 0


Michal Amit, Joseph Itskovitz-Eldor


Accelerating stem cell technologies

Terms of use | Privacy Policy  |  © 2021

© 2021 Accellta. All Rights Reserved. Designed By Netron Israel Ltd.


Accessibility Initiative Badge

Register / Login